Literature DB >> 35373009

Hematuria and Flank Pain in a Patient with Sickle Cell Trait Who Is Taking NSAIDs.

Travis D Homan1, Jonathan B Buck2, Kana N Miyata2.   

Abstract

Entities:  

Keywords:  NSAIDs; anti-inflammatory agents; clinical nephrology; hematuria; non-steroidal; papillary necrosis; sickle cell trait

Mesh：

Substances：

Year:  2021        PMID： 35373009      PMCID： PMC8785852          DOI： 10.34067/KID.0003642021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  5 in total

Review 1.  Renal papillary necrosis in patients with sickle cell disease: How to recognize this 'forgotten' diagnosis.

Authors:  Michaël M E L Henderickx; Tim Brits; Karen De Baets; Mattias Seghers; Philip Maes; Dominique Trouet; Stefan De Wachter; Gunter De Win
Journal:  J Pediatr Urol       Date:  2017-03-07       Impact factor: 1.830

2.  Protracted, gross hematuria in sickle cell trait: response to multiple doses of 1-desamino-8-D-arginine vasopressin.

Authors:  A Moudgil; E S Kamil
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 3.  Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography.

Authors:  Dae Chul Jung; Seung Hyup Kim; Sung Il Jung; Sung Il Hwang; Sun Ho Kim
Journal:  Radiographics       Date:  2006 Nov-Dec       Impact factor: 5.333

4.  Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease.

Authors:  Alexander Gabrovsky; Abimbola Aderinto; Abimbole Aderinto; Melissa Spevak; Elliot Vichinsky; Linda M S Resar
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

5.  Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis. Conservative approach using a balloon ureteral catheter to tamponade the papilla bleeding.

Authors:  A Herard; J Colin; Y Youinou; E Drancourt; B Brandt
Journal:  Eur Urol       Date:  1998-08       Impact factor: 20.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.